VALERIE MILLER: Open Payments
NPI 1801348982 · SUMMERVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,538 in 77 payments from 22 companies in 2025. Trend: 2023 $1,659 · 2024 $1,313 · 2025 $1,538
Food & beverage: $1,538
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 15 | $276 |
| Vanda Pharmaceuticals Inc. | 12 | $217 |
| ABBVIE INC. | 16 | $198 |
| AstraZeneca Pharmaceuticals LP | 1 | $121 |
| Lilly USA, LLC | 5 | $110 |
| Sage Therapeutics, LLC | 3 | $101 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Axsome Therapeutics, Inc. | 2 | $53 |
| Alkermes, Inc. | 2 | $51 |
| Novo Nordisk Inc | 3 | $51 |
Products named: COBENFY, HETLIOZ, BREZTRI, ZURZUVAE, VRAYLAR, MOUNJARO, REXULTI, Auvelity.
Industry payments across SC — which companies pay providers there.
